Home
Company
Therapeutic Focus
Pipeline
Oxylanthanum Carbonate (OLC)
UNI-494
Investors
Resources
Contact
Archives:
Resources
UNI-494 InVitro Drug Interaction- Poster
May 15, 2023
Oxylanthanum Carbonate (OLC) – Phase 1 Clinical Study Poster
May 12, 2023
UNI-494 Preclinical PK Poster
May 12, 2023
←
Newer Posts